AJP - Heart Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 281: H1104-H1112, 2001;
0363-6135/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, A.
Right arrow Articles by Foster, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, A.
Right arrow Articles by Foster, E.
Vol. 281, Issue 3, H1104-H1112, September 2001

LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice

Akihiro Nakamura1, D. Gregg Rokosh2, Mariemma Paccanaro1, Rupsa R. Yee1, Paul C. Simpson2, William Grossman1, and Elyse Foster1

1 Division of Cardiology, Department of Medicine, University of California, San Francisco 94143; and 2 Cardiology Division and Research Service, Veterans Affairs Medical Center, San Francisco, California 94121


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Transverse aortic constriction (TAC) is an effective technique for inducing left ventricular (LV) hypertrophy in mice. With the use of transthoracic echocardiography and Doppler measurements, we studied the effects of an acute increase in pressure overload on LV contractile performance and peak systolic wall stress index (WSI) at early time points after TAC and the time course of the development of LV hypertrophy in mice. The LV mass index was similar between TAC and sham-operated mice at postoperative day 1 but progressively increased in TAC mice by day 10. There was no further increase in the LV mass index between postoperative days 10 and 20. On day 1, whereas peak systolic WSI increased significantly, the LV ejection fraction (LVEF) and percent fractional shortening (%FS) decreased in TAC mice compared with sham-operated mice. By day 10, peak systolic WSI, LVEF, and %FS had recovered to baseline levels and were not significantly different between postoperative days 10 and 20. Thus LV systolic performance in mice declines immediately after TAC, associated with increased peak systolic WSI, but recovers to baseline levels with the development of compensatory LV hypertrophy over 10-20 days.

echocardiography; left ventricular function


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

THE DEVELOPMENT OF LEFT VENTRICULAR (LV) hypertrophy is a basic adaptive response to increased hemodynamic load. LV wall stress is believed to be an important determinant of the degree and type of LV hypertrophy induced by pressure overload (5, 6). LV systolic performance at early time points after aortic constriction has not been studied extensively, and very little information is available concerning the time course for the development of LV hypertrophy. The mouse has become an increasingly important subject for hemodynamic studies with the availability of transgenic models, but invasive measurements in mice are fraught with significant morbidity and mortality. Echocardiography is well suited for serial noninvasive measurements of LV mass to determine the rate of development of hypertrophy and its relationship to changes in wall stress as well as the acute effects on systolic performance.

With the use of transverse aortic constriction (TAC), an effective technique for inducing LV hypertrophy in mice (15), this study was designed to assess continuous-wave (CW) Doppler measurements across the constriction coupled with noninvasively measured blood pressure for an adequate estimation of peak LV systolic pressure, which together with simultaneous echocardiographic measurement of LV mass (LVM), wall thickness, and chamber diameter could be used for calculation of the LV peak systolic wall stress index (WSI). Our findings support the hypothesis that LV peak systolic wall stress is inversely related to systolic performance during the development of hypertrophy induced by acute LV pressure overload, and we define the time course for the development of LV hypertrophy in the pressure-overload model.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

This study was approved by the committee on Animal Research of the University of California at San Francisco, and the animals were maintained in accordance with the guidelines of the University of California Animal Use Committee and the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Publication No. 85-23, Revised 1996).

Animal preparations. Twenty-three male mice (C57BL/6, age 8-9 wk, 24-26 g body wt, Charles River Laboratories; Gilroy, CA), housed in an air-conditioned room with a 12:12-h light-dark cycle and fed standard mouse chow and tap water ad libitum, underwent TAC and survived the initial 24 h. Anesthesia was induced with 3% isoflurane gas and maintained with 1.5% isoflurane in room air supplemented with 100% O2 (3). The surgical procedure for producing TAC in mice was performed as described by Rockman et al. (15). In brief, the aortic arch was isolated by entering the extrapleural space above the first rib, and the transverse aorta was isolated between the right and left carotid arteries. A 7-0 nylon suture ligature was tied around the transverse aorta against a 27-gauge needle to produce a 65-70% constriction (outer diameter, ~0.3 mm) after the removal of the needle. Nine age-matched animals underwent the same surgical procedure except for TAC (sham). The overall 20-day mortality rates, excluding deaths in the initial 24 h, were 39% (9 of 23) for TAC mice; none of the sham-operated mice died. Four of the TAC mice died within 1-3 days after the procedure, and five mice died within 3-20 days due to heart failure.

Transthoracic echocardiographic Doppler studies. Mice were anesthetized with 3% isoflurane and maintained with 1.5% isoflurane in room air supplemented with 100% O2. Anesthetized animals underwent transthoracic echocardiographic Doppler studies at baseline and on postoperative days 1, 3, 10, and 20 with a commercially available system (Acuson Sequoia c256; Mountain View, CA) using a 15-MHz linear array transducer (15L8). After the anterior chest was shaved, the animals were placed on a warming pad to maintain normothermia. Two-dimensional (2D) imaging was performed at a minimum depth setting of 2 cm, and the enhanced resolution imaging function was activated with a region of interest adjusted to the heart size. Gain was set for best imaging, and compression was 60 dB. Animals were imaged in a shallow left lateral decubitus position. The echocardiographic gel was warmed before use to avoid hypothermia. Care was taken to avoid excessive pressure on the thorax, which can induce bradycardia. 2D long-axis images of the LV were obtained at the plane of the aortic and mitral valves with adequate visualization of the LV apex, and a short-axis image was recorded at the level of the papillary muscles. A 2D guided M-mode echocardiogram was recorded through the anterior and posterior LV walls at a sweep speed of 200 mm/s. Images were digitally acquired and stored on magnetooptical disk (SONY EDM-230C, Sony; Tokyo, Japan). All primary measurements were made from digital images captured on cine loops at the time of study with the use of a specialized software package (Acuson Sequoia). For each study, measurements were made from >= 3 beats [average beats, 3.8 ± 0.4 beats (mean ± SD); range, 3-6 beats].

2D guided M-mode images were obtained at the level of the papillary muscle tips, and measurements were then performed to obtain the LV internal dimension (LVID; in mm), interventricular septum thickness, and posterior wall thickness (PWT; in mm) with the use of the leading-edge convention adapted by the American Society of Echocardiography (18). LV percent fractional shortening (%FS) was calculated as
%FS<IT>=</IT>[(LVID<SUB>d</SUB><IT>−</IT>LVID<SUB>s</SUB>)<IT>/</IT>LVID<SUB>d</SUB>]<IT>×</IT>100 (1)
where d indicates diastole and s indicates systole.

2D-derived measurements included LV end-diastolic epicardial and endocardial area tracing of the short-axis images at the level of the papillary muscles and endocardial tracings of the long-axis images of end-diastolic and end-systolic frames. With the use of long-axis images, the end-diastolic (EDV) and end-systolic LV volumes (ESV) were calculated by the modified Simpson's method (19, 20), and the LV ejection fraction (LVEF) was then calculated as
LVEF (%)<IT>=</IT>[(EDV<IT>−</IT>ESV)<IT>/</IT>EDV]<IT>×</IT>100 (2)
LVM was calculated by 2D measurement based on the truncated ellipsoid method (LVMTE) (20), and the LVM (in mg) divided by body weight (in g) was also determined as the LVM index (in mg/g). The LVMTE was calculated as
LVM<SUB>TE</SUB> (in mg)<IT>=</IT>1.05<IT>&pgr;</IT>{(<IT>b+</IT><IT>t</IT>)<SUP>2</SUP>[2<IT>/</IT>3(<IT>a+t</IT>)<IT>+d</IT> (3)

<IT>−d</IT><SUP>3</SUP><IT>/</IT>3(<IT>a+t</IT>)<SUP>2</SUP>]<IT>−b</IT><SUP>2</SUP>(2<IT>/</IT>3<IT>a+d−d</IT><SUP>3</SUP><IT>/</IT>3<IT>a</IT><SUP>2</SUP>)}
where a is the semimajor axis, b is the semiminor axis or calculated radius at the level of the papillary muscle tip, d is the truncated semimajor axis, and t is the calculated wall thickness at the level of the papillary muscle tip.

The peak velocity of blood flow in the ascending aorta was obtained from pulse-wave Doppler spectra of the ascending aortic flow, which was recorded from the apical two-chamber view by minor anterior angulation of the transducer, with the sample volume placed near the aortic valve and adjusted to the position where velocity was maximal. All Doppler spectra were recorded at a sweep speed of 200 mm/s for off-line analysis.

To perform serial measurements of the LV peak systolic WSI, we measured the peak gradient across the constriction and tail-cuff systolic blood pressure (TAC mice, n = 7; sham-operated mice, n = 5) on the same day as the LV systolic function and LVM measurements. We obtained CW Doppler signals across the region of constriction by angulating the transducer until the maximal audible signal was obtained. The CW Doppler studies were performed at postoperative days 1, 3, 10, and 20 with an Acuson Sequoia c256 system equipped with a 2.0-MHz auxiliary CW probe. The peak gradients across the constriction were calculated from the maximal blood flow velocity of the Doppler recording by means of the modified Bernoulli equation: P = 4v2, where P is the peak (pressure) gradient (in mmHg) and v is the maximal velocity across the constriction (in m/s). LV peak systolic WSI (5, 6) was calculated as
WSI (in g<IT>/</IT>cm<SUP>2</SUP>) (4)

<IT>=</IT>(1.35<IT>×</IT>P<IT>×</IT>LVID<SUB>s</SUB>)<IT>/</IT>{(4<IT>×</IT>PWT<SUB>s</SUB>)[1<IT>+</IT>(PWT<SUB>s</SUB><IT>/</IT>LVID<SUB>s</SUB>)]}
where P is the peak LV systolic pressure (in mmHg) and 1.35 is the conversion factor from millimeters of Hg to grams per centimeter squared. LVIDs and PWTs were measured from the M-mode echocardiogram. All measurements were made at peak systole, as defined by the time point corresponding to the smallest cavity dimension. Peak LV systolic pressure was estimated as the sum of the peak gradient measured by CW Doppler added to tail-cuff systolic blood pressures.

Measurement of systolic blood pressure. Systolic blood pressure was measured in the conscious state (TAC mice, n = 7; sham-operated mice, n = 5) using a noninvasive computerized tail-cuff system (BP-2000, Visitech Systems; Apex, NC) as described by others (13). The reported values are the means of at least three recordings of 20 cardiac cycles per recording taken on the same time of day at baseline and at postoperative days 1, 3, 10, and 20.

Catheterization studies. To validate the peak gradient measured by CW Doppler, TAC mice (n = 14) underwent catheterization studies at postoperative day 20, just before death. Two of the mice died at catheterization. In brief, the right (upstream of the constriction) and left carotid arteries (downstream of the constriction) of anesthetized animals were exposed and cannulated with polyethylene-10 catheters connected to calibrated fluid-filled transducers (COBE transducer). Left and right carotid pressures were measured simultaneously and recorded digitally at 500 Hz (MP100 Workstation, BIOPAC Systems; Santa Barbara, CA).

Autopsy. The mice were immediately killed after catheterization studies at postoperative day 20. In 12 of the mice (TAC mice, n = 7; sham-operated mice, n = 5), the hearts were excised, and the right ventricular free wall, major blood vessels, and both atria were removed. The LV was opened and blotted once with gauze to remove intracavitary blood. The isolated LV, including the entire septum, was then weighed.

Measurement variability. To assess the variability of echocardiographic Doppler parameters, a total of 60 measurements were read independently by two observers (A. Nakamura and M. Paccanaro) in 12 animals. A single observer (A. Nakamura) repeated the measurements several weeks later. Inter- and intraobserver errors were calculated as the difference between the two observations divided by the means of the observations and expressed as a percentage (23). The agreement for both inter- and intraobserver variabilities was evaluated by correlation coefficients.

Statistical analysis. All data are expressed as means ± SD. Statistical analyses were performed with commercially available software (StatView version 4.02, Abacus Concepts; Berkeley, CA). Comparisons of values were done between sham-operated and TAC animals using an unpaired Student's t-test. Statistical comparisons of serial changes were performed by a repeated-measures ANOVA followed by Fisher's protected least significant difference test. The relationship between variables was examined by linear regression analysis. A value of P < 0.05 was considered to be statistically significant.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The results of echocardiographic and Doppler studies in surviving mice are summarized in Table 1, and heart rate and systolic blood pressure during tail-cuff measurements are summarized in Table 2. Representive 2D long- and short-axis images and M-mode tracings of the LV in a TAC mouse are shown in Fig. 1.

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Effect of TAC on LV hypertrophy and function as measured by the changes in LV parameters in mice


                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Tail-cuff HR and systolic BP



View larger version (119K):
[in this window]
[in a new window]
 
Fig. 1.   Representative echocardiograms of the left ventricle (LV) in a mouse with transverse aortic constriction (TAC). Two-dimensional long- (top) and short-axis images (middle) and M-mode tracings (bottom) were recorded from the same TAC mouse. LV anterior wall (AW), posterior wall (PW), and internal dimension (LVID) are indicated on the M-mode tracing. Scale bars for size on the long- and short-axis images and for both size and time on the M-mode tracing are shown. On day 1, the TAC mouse shows no significant increase in LV wall thickness compared with baseline, and LV wall motion recorded by M-mode is significantly lower than that at baseline. On day 10, LV wall thickness is significantly greater than that on baseline or day 1, and LV wall motion shows a recovery to the baseline level.

LV hypertrophy develops rapidly after TAC. The time course of LV hypertrophy acutely after TAC has not been described previously. To assess this, we banded the transverse aorta of adult male mice and studied the LV wall thickness, LVID, and LVM index from day 1 to day 20 by echocardiography. The LV wall thickness was not significantly different between TAC and sham-operated mice at postoperative day 1 but progressively increased in TAC mice by day 10 and showed no further increase at day 20 (Fig. 2A). The LVID at end diastole was not significantly different between TAC and sham-operated mice at any time point (Fig. 2A). At postoperative day 1, the LVM index was not significantly different between TAC and sham-operated mice [3.24 ± 0.42 mg/g in TAC mice vs. 3.13 ± 0.34 mg/g in sham-operated mice, P = not significant (NS)] but was 34% greater in TAC mice than sham-operated mice by day 3 and 75% greater by day 10 (Fig. 2B). There was no further increase in the LVM index between postoperative day 10 and day 20 (5.33 ± 0.71 vs. 5.52 ± 0.83 mg/g, P = NS). Autopsy LV weight (x) in surviving mice showed a strong correlation with echocardiographic LVM (y): y = 0.966x - 7.903, r = 0.928, P < 0.0001, n = 12. Body weight was not significantly different between TAC and sham-operated mice at baseline and day 20 (baseline: 23.8 ± 0.6 vs. 23.6 ± 0.6 g, P > 0.2; day 20: 24.6 ± 0.8 vs. 24.2 ± 1.2 g, P = NS; Table 1).


View larger version (25K):
[in this window]
[in a new window]
 
Fig. 2.   Effects of TAC on diastolic LV posterior wall thickness (PWTd) and diastolic LVID (LVIDd) (A), LV hypertrophy (B), and LV systolic function as assessed by LV ejection fraction (LVEF; C) and percent fractional shortening (%FS; D). Values are presented as means ± SD. Sham, sham-operated mice (n = 9); TAC, mice with TAC (n = 14). *P < 0.01 and **P < 0.05 vs. sham-operated mice at the same time point; #P < 0.01, dagger P < 0.01, and Dagger P < 0.01 vs. TAC mice at baseline, day 1, and day 3, respectively; §P < 0.01 and ¶ P < 0.05 vs. TAC mice at day 10.

LV systolic function deteriorates immediately after TAC. To assess LV systolic function after TAC, we performed 2D and M-mode measurements beginning on day 1 in the same mice. On day 1, LVEF and %FS were significantly lower in TAC mice than sham-operated mice (LVEF: 41 ± 7 vs. 61 ± 6%, P < 0.01; %FS: 16 ± 4 vs. 27 ± 4%, P < 0.01; Fig. 2, C and D). The difference narrowed by day 3, and by day 10 LVEF and %FS in TAC mice had recovered to baseline levels. LVEF and %FS in TAC mice were not significantly different between postoperative days 10 and 20 (LVEF: 62 ± 6 vs. 64 ± 5%, P > 0.7; %FS: 28 ± 4 vs. 29 ± 4%, P = NS). On day 1, the peak flow velocity of the ascending aorta in TAC mice remarkably decreased to 69% of that at baseline. Thereafter, it increased with time, coinciding with the improvement of LV systolic function, and normalized by day 10; there was no significant difference between postoperative days 10 and 20 (0.75 ± 0.15 vs. 0.76 ± 0.16 m/s, P = NS; Table 1).

Transconstriction CW flow pattern as an index of gradient. To assess the degree of afterload imposed by TAC, we measured peak velocities across the constriction by CW Doppler. The peak gradient by CW Doppler was measurable in all TAC mice and progressively increased (day 1: 28 ± 7 mmHg vs. day 3: 46 ± 11 mmHg, P < 0.01; day 3 vs. day 10: 68 ± 11 mmHg, P < 0.01) concordant with the increase in aortic flow velocity (Table 1). The peak gradient in TAC mice was not significantly different between days 10 and 20 (68 ± 11 vs. 62 ± 9 mmHg, P = NS; Fig. 3B). The peak gradient measured by CW Doppler (x) showed a good correlation with echocardiographc LVM (y): y = 0.057x + 2.084, r = 0.922, P < 0.0001 (Fig. 3C).


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 3.   A: representive continuous-wave (CW) Doppler flow pattern across the TAC on postoperative days 3, 10, and 20 in a mouse with TAC. On day 3, the peak velocity (V) was 3.46 m/s, which (according to the modified Bernoulli equation) is equivalent to a peak instantaneous gradient (P) of 48 mmHg. It increased to 4.33 m/s (peak gradient: 75 mmHg) on day 10 and 4.21 m/s (71 mmHg) on day 20. B: effects of TAC on the peak gradient measured by CW Doppler echocardiography. NS, not significant. C: correlation between the peak gradient measured by CW Doppler echocardiography (x) and LV mass index (y).

The peak gradient by CW Doppler was compared with the invasively measured gradient at day 20. Representive CW Doppler flow pattern across the constriction and pressure tracings of simultaneous right (upstream) and left (downstream) carotid arteries in the same mouse are shown in Fig. 4, A and B, respectively. Peak gradients measured by CW Doppler were 50-85 mmHg (mean: 66 ± 11 mmHg, n = 12) at postoperative day 20, whereas catheter gradients were 54-131 mmHg (mean: 88 ± 27 mmHg, n = 12). Thus there was a systematic underestimation of the gradients by Doppler, possibly related to a suboptimal angle of Doppler interrogation. Nevertheless, the peak gradient measured by catheter (x) and peak gradients by CW Doppler (y) showed a good correlation: y = 0.352x + 35.094, r = 0.867, P < 0.0001 (Fig. 4C). The mean difference between the peak gradient by catheterization and Doppler measurement was 22 ± 18 mmHg (mean ± SD). Pressure upstream of the constriction measured by catheterization (x) and the value of peak gradient measured by CW Doppler added to tail-cuff systolic blood pressure (y) also showed a good correlation: y = 0.468x + 80.013, r = 0.874, P < 0.0001 (Fig. 4D).


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 4.   A: representative CW Doppler flow pattern across the TAC on postoperative day 20. Peak velocity is 3.69 m/s, which (according to the modified Bernoulli equation) is equivalent to a peak instantaneous gradient of 54.5 mmHg. B: analog recordings of simultaneous pressures measured in the left (top) and right carotid arteries (bottom) from the same mouse as in A. The difference in peak systolic pressures from the right and left carotid arteries is 57 mmHg. C: correlation between the CW Doppler gradient (y) and catheter gradient (x) across the constriction in mice with TAC. D: correlation between the value of the CW Doppler gradient added to the tail-cuff systolic pressure (y) and pressure upstream to the constriction measured by the catheterization method (x).

LV peak systolic WSI during development of LV hypertrophy. The peak LV systolic pressure was estimated by adding the tail-cuff pressure to the peak gradient across the constriction (Table 2) and was used to estimate the LV peak systolic WSI. As seen in Fig. 5A, on postoperative day 1, the LV peak systolic WSI in TAC mice was significantly greater than that in sham-operated mice: 259 ± 40 vs. 148 ± 13 g/cm2, P < 0.01. The difference narrowed by day 3, and by day 10 the LV peak systolic WSI in TAC mice had recovered to baseline levels. The LV peak systolic WSI in TAC mice was not significantly different between postoperative days 10 and 20 (131 ± 24 vs. 136 ± 8 g/cm2, P = NS; Fig. 5A). LV %FS was linearly and inversely related to the LV peak systolic WSI (Fig. 5B).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 5.   A: effects of TAC on the LV peak systolic wall stress index (WSI). Values are presented as means ± SD; n = 5 sham-operated mice and 7 TAC mice. *P < 0.05 and dagger P < 0.01 vs. sham-operated mice at the same time point. B: correlation between the LV percent fractional shortening (%FS) (y) and LV peak systolic WSI (x).

Inadequate LV hypertrophy in TAC mice. Of the five TAC mice who died between days 3 and 20, all five had echocardiographic Doppler studies on day 3 and four had echocardiographic Doppler studies on day 10. On day 3, the LVM index and LVEF were not significantly different between the TAC mice who died (n = 5) and those who survived (n = 14) (LVM index: 3.92 ± 0.49 vs. 4.21 ± 0.71 mg/g, P = NS; LVEF: 45 ± 7 vs. 55 ± 9% , P = 0.2), although the LVM index and LVEF tended to be higher in the survivors. On day 10, the LVM index was lower in those who died, but the difference did not reach statistical signficance (4.58 ± 1.26 vs. 5.33 ± 0.71; P = NS). However, the LVEF in the TAC mice who died (n = 4) was significantly lower than in survivors (n = 14) (LVEF: 44 ± 10 vs. 62 ± 6%, P < 0.05). However, there was overlap among the animals who died and those who survived. The LV peak systolic WSI was not significantly different between TAC mice who died and those who survived on postoperative day 3 (206 ± 15 vs.175 ± 20 g/cm2, P = NS), but it was significantly greater on day 10 in those mice who died prematurely (222 ± 43 vs. 126 ± 32 g/cm2, P < 0.01). By day 10, the LV peak systolic WSI in TAC mice who died had not recovered to baseline levels (day 1: 166 ± 14; day 3: 206 ± 15 vs. day 10: 222 ± 43 g/cm2).

Inter- and intraobserver variability. The results of inter- and intraobserver variabilities for echocardiographic measurements are summarized in Table 3. Overall, inter- and intraobserver variabilities were low, and agreements were excellent for all echocardiographic Doppler parameters. The coefficients for inter- and intraobserver measurements ranged from 0.87 to 0.97 and 0.86 to 0.98, respectively. The inter- and intraobserver variabilities for the LV peak systolic WSI were 5.6 ± 5.2 and 4.6 ± 4.6%, respectively. The coefficients for the LV peak systolic WSI were 0.92 and 0.94, respectively.

                              
View this table:
[in this window]
[in a new window]
 
Table 3.   Inter- and intraobserver of echocardiographic Doppler measurements


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The new finding of this study is that the LV peak systolic WSI rose and contractile performance deteriorated immediately after TAC in mice but recovered to baseline levels with the development of compensatory LV hypertrophy over 10-20 days. The LV peak systolic WSI was inversely related to systolic LV performance during the development of hypertrophy induced by acute LV pressure overload.

LV contractile function before the transition to stable compensated hypertrophy has been incompletely examined in mice because of difficulty in performing serial studies. In this study, we performed transthoracic echocardiography in mice using a newly developed high-frequency linear transducer, and this is the first report as to the time course of the LV peak systolic WSI, contractile function, and hypertrophy immediately after TAC. Our observations raise the question of what mechanisms are responsible for the myocardial dysfunction and its recovery. In cardiac muscle, contraction and relaxation are regulated by cyclic release and removal of Ca2+ by the sarcoplasmic reticulum, and many factors, including sarco(endo)plasmic reticulum Ca2+-ATPase (12, 14), phospholamban (2, 12), ryanodine (2), calsequestrin (22), and the Na+-Ca2+ exchanger (25), are involved in the calcium homeostasis that plays an important role in cardiac function. This methodology forms the basis for the future study of the relationship between molecular and physiological alterations in pressure-overload-induced LV hypertrophy.

The TAC model is a stable microsurgical technique that has been developed as in vivo mouse model of myocardial hypertrophy to investigate cardiac gene expression during pressure-induced LV hypertrophy in normal and transgenic mice (4, 15, 16). Other alternative sites for aortic constriction include the ascending (7) and abdominal aorta (21). With the use of supravalvular constriction, it is difficult to reliably measure the peak gradients across the constriction. Moreover, ascending aorta constriction is more likely to cause an excessive and abrupt overload on the LV in mice. Abdominal aortic constriction leaves a considerable part of the circulation as a reactive vascular bed. Thus, with these alternative techniques, the precise hemodynamic afterload imposed on the LV in mice cannot be measured. With the use of the TAC model, we were able to measure the hemodynamic load on the ventricle in vivo by performing serial noninvasive measurements of the peak-systolic WSI.

With the use of CW Doppler echocardiography, the signals of continuous flow pattern across the constriction were detected in all TAC mice. Our results showed that the peak gradient across the constriction, which was similar to that measured by invasive technique, increased with time, coinciding with development of LV hypertrophy and improvement of LV systolic function. Although CW Doppler echocardiography was a relatively simple technique that allowed repetitive noninvasive detection of continuous flow pattern across the constriction, peak gradients measured by CW Doppler underestimated those measured invasively, probably due to angle dependency of the recorded frequency shift.

From the viewpoint of myocardial mechanics, myocyte systolic load can be estimated by LV systolic wall stress, which is an important determinant of LV systolic performance (10). Myocardial stress is believed to be the major mechanical determinant of LV hypertrophy rather than LV pressure or aortic impedance (1, 6, 8). One of the goals of this study was to assess the feasibility of longitudinal noninvasive measurements of the peak systolic WSI in TAC mice. Although a method of measuring peak LV systolic pressure by means of ventricular catheterization has been developed in TAC mice (9, 16), it requires instrumentation and microsurgical techniques and is difficult to perform repeatedly in the same animal, thereby limiting longitudinal studies. For this reason, we developed a novel noninvasive method by which upstream blood pressure across the constriction would be predictable by combination of CW Doppler echocardiography and tail-cuff blood pressure measurements.

Interestingly, several of the animals who died by postoperative day 20 appeared to have insufficient LV hypertrophy compared with surviving TAC mice. LV systolic performance in these mice had not recovered. Although the numbers are too small to allow a firm conclusion, these data suggest that inadequate hypertrophy may lead to persistent systolic dysfunction and may have contributed to mortality. Further studies, including those in transgenic models, may elucidate the maladaptive mechanisms to pressure overload.

For evaluation of LV systolic performance, the peak flow velocity of the ascending aorta was also longitudinally assessed using pulse-wave Doppler echocardiography and showed changes similar to LVEF and %FS (Table 1). Although we did not evaluate LV systolic performance invasively, it has been reported that the peak aortic velocity was highly correlated with the maximal change in pressure over time (17, 24).

A limitation of this study is that measurements of the peak gradients by CW Doppler were performed under anesthesia, whereas those of tail-cuff blood pressures were measured in the awake animals. These conditions could potentially underestimate the LV systolic pressure and, therefore, the calculated WSI. However, there was a very close correlation between pressures upstream across the constriction measured by invasive method under anesthesia and peak gradients by CW Doppler added to tail-cuff systolic blood pressures. In this study, the maximal "audible" signal was obtained for measurement of the peak pressure gradient across the constriction. The measurements in the conscious state may introduce artifacts related to fear or pain in the experimental animals. Isoflurane gas used in echocardiographic Doppler studies has been reported as an anesthetic agent with only minor hemodynamic effects (11), and our results did not show a marked slowing of heart rate in anesthetized animals. Although this study minimized the potential effects of anesthetic agent on cardiac function, repeat studies in conscious animals may provide additional insights into LV cardiac performance in the pressure-overload model.

With the advent of transgenic and knockout technology, genetically altered mice with remarkable cardiovascular phenotypes are now available. To benefit from the full potential of these genetically engineered mice, it is important to develop noninvasive approaches for accurate serial measurements of cardiac morphology and function in intact animals. The techniques developed in this study should facilitate investigation of the early effects of altered hemodynamic loading in intact mice.

In conclusion, serial changes in LV mass and systolic function during the adaptation to pressure overload were studied in a TAC murine model. This is the first demonstration that LV systolic performance declines immediately after TAC and recovers with the development of compensatory LV hypertrophy. Furthermore, our results demonstrate the technical feasibility of obtaining high-quality CW Doppler signals from the flow across the constriction in TAC mice and assessing peak LV systolic pressure for assessing the LV peak systolic WSI from measurements of peak gradients across the constriction and tail-cuff blood pressure. Because the LV peak systolic WSI is an important determinant of cardiac performance, our results provide insight into the hemodynamic mechanism of pressure-overload induced-hypertrophy.


    ACKNOWLEDGEMENTS

This study was supported by the University of California at San Francisco Cardiology Council and by National Heart, Lung, and Blood Institute Research Grants HL-31113, HL-42150, and HL-54890.


    FOOTNOTES

This work was presented in part at the 72nd Scientific Session of the American Heart Association, Atlanta, GA, 1999 and was previously published in abstract form (Circulation 100: I-119, 1999).

Address for reprint requests and other correspondence: E. Foster, Adult Echocardiographic Laboratory, Div. of Cardiology, Univ. of California, San Francisco, 505 Parnassus Ave., M314, San Francisco, CA 94143-0214 (E-Mail: foster{at}medicine.ucsf.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 6 September 2000; accepted in final form 18 April 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Aoyagi, T, Fujii AM, Flanagan MF, Arnold LW, Brathwaite KW, Colan SD, and Mirsky I. Transition from compensated hypertrophy to intrinsic myocardial dysfunction during development of left ventricular pressure-overload hypertrophy in conscious sheep. Circulation 88: 2415-2425, 1993[Abstract/Free Full Text].

2.   Arai, M, Alpert NR, MacLennan DH, Barton P, and Periasamy M. Alterations in sarcoplasmic reticulum gene expression in human heart failure. A possible mechanism for alterations in systolic and diastolic properties of the failing myocardium. Circ Res 72: 463-469, 1993[Abstract/Free Full Text].

3.   Bryan, RM, Jr, Cherian L, and Robertson C. Regional cerebral blood flow after controlled cortical impact injury in rats. Anesth Analg 80: 687-695, 1995[Abstract].

4.   Choi, DJ, Koch WJ, Hunter JJ, and Rockman HA. Mechanism of beta -adrenergic receptor desensitization in cardiac hypertrophy is increased beta -adrenergic receptor kinase. J Biol Chem 272: 17223-17229, 1997[Abstract/Free Full Text].

5.   Grossman, W. Cardiac hypertrophy: useful adaptation or pathologic process? Am J Med 69: 576-584, 1980[ISI][Medline].

6.   Grossman, W, Jones D, and McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56: 56-64, 1975.

7.   Hamawaki, M, Coffman TM, Lashus A, Koide M, Zile MR, Oliverio MI, DeFreyte G, Cooper G, IV, and Carabello BA. Pressure-overload hypertrophy is unabated in mice devoid of AT1A receptors. Am J Physiol Heart Circ Physiol 274: H863-H873, 1998.

8.   Hoit, BD, Khan ZU, Pawloski-Dahm CM, and Walsh RA. In vivo determination of left ventricular wall stress-shortening relationship in normal mice. Am J Physiol Heart Circ Physiol 272: H1047-H1052, 1997[Abstract/Free Full Text].

9.   Hunter, JJ, Tanaka N, Rockman HA, Ross J, Jr, and Chien KR. Ventricular expression of a MCL-2v-Ras fusion gene induces cardiac hypertrophy and selective diastolic dysfunction in transgenic mice. J Biol Chem 270: 32173-33178, 1995.

10.   Isoyama, S, Wei JY, Izumo S, Fort P, Schoen FJ, and Grossman W. Effect of age on the development of cardiac hypertrophy produced by aortic constriction in the rat. Circ Res 61: 337-345, 1987[Abstract/Free Full Text].

11.   Kersten, JR, Schmeling TJ, Hettrick DA, Pagel PS, Gross GJ, and Warltier DC. Mechanism of myocardial protection by isoflurane. Role of adenosine triphosphate-regulated potassium (KATP) channels. Anesthesiology 85: 794-807, 1996[ISI][Medline].

12.   Kiss, E, Ball NA, Kranias EG, and Walsh RA. Differential changes in cardiac phospholamban and sarcoplasmic reticular Ca2+-ATPase protein levels: effects on Ca2+ transport and mechanics in compensated pressure-overload hypertrophy and congestive heart failure. Circ Res 77: 759-764, 1995[Abstract/Free Full Text].

13.   Krege, JH, Hodgin JB, Hagaman JR, and Smithies O. A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 25: 1111-1115, 1995[Abstract/Free Full Text].

14.   Levitsky, D, De La Bastie D, Schwartz K, and Lompre AM. Ca2+-ATPase and function of sarcoplasmic reticulum during cardiac hypertrophy. Am J Physiol 261, Suppl4: 23-26, 1991.

15.   Rockman, HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J, Jr, and Chien KR. Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88: 8277-8281, 1991[Abstract/Free Full Text].

16.   Rockman, HA, Wachhorst SP, Mao L, and Ross J, Jr. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol Heart Circ Physiol 266: H2468-H2475, 1994[Abstract/Free Full Text].

17.   Sabbah, HN, Khaja F, Brymer JF, McFarland TM, Albert DE, Sayder JE, Goldstein S, and Stein PD. Noninvasive evaluation of left ventricular performance based on peak aortic blood acceleration measured with a continuous-wave Doppler velocity meter. Circulation 74: 323-329, 1986[Abstract/Free Full Text].

18.   Sahn, DJ, DeMaria A, Kisslo J, and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58: 1072-1083, 1978[Abstract/Free Full Text].

19.   Scherrer-Crosbie, M, Steudel W, Hunziker PR, Foster GP, Garrido L, Liel-Cohen N, Zapol WM, and Picard MH. Determination of right ventricular structure and function in normoxic and hypoxic mice: a transesophageal echocardiographic study. Circulation 98: 1015-1021, 1998[Abstract/Free Full Text].

20.   Schiller, NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnittger I, Silverman NH, and Tajik AJ. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 2: 358-367, 1989[Medline].

21.   Shizukuda, Y, Buttrick PM, Geenen DL, Borczuk AC, Kitsis RN, and Sonnenblick EH. beta -Adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol Heart Circ Physiol 275: H961-H968, 1998[Abstract/Free Full Text].

22.   Takahashi, T, Allen PD, Lacro RV, Dennis AR, Schoen FJ, Grossman W, Marsh JD, and Izumo S. Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest 90: 927-935, 1992.

23.   Tanaka, M, Dalton N, Mao L, Rockman HA, Peterson KL, Gottshall KR, Hunter JJ, Chien KR, and Ross J, Jr. Transthoracic echocardiography in models of cardiac disease in the mouse. Circulation 94: 1109-1117, 1996[Abstract/Free Full Text].

24.   Wallmeyer, K, Wann LS, Sagar KB, Kalbfleisch J, and Klopfenstein HS. The influence of preload and heart rate on Doppler echocardiographic indexes of left ventricular performance: comparison with invasive indexes in an experimental preparation. Circulation 74: 181-186, 1986[Abstract/Free Full Text].

25.   Weinberg, EO, Thienelt CD, Katz SE, Bartunek J, Tajima M, Rohrbach S, and Douglas PS. Gender differences in molecular remodeling in pressure overload hypertrophy. J Am Coll Cardiol 34: 264-273, 1999[Abstract/Free Full Text].


Am J Physiol Heart Circ Physiol 281(3):H1104-H1112



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
G. Cheng, M. R. Zile, M. Takahashi, C. F. Baicu, D. D. Bonnema, F. Cabral, D. R. Menick, and G. Cooper 4th
A direct test of the hypothesis that increased microtubule network density contributes to contractile dysfunction of the hypertrophied heart
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2231 - H2241.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Chess, B. Lei, B. D. Hoit, A. M. Azimzadeh, and W. C. Stanley
Deleterious effects of sugar and protective effects of starch on cardiac remodeling, contractile dysfunction, and mortality in response to pressure overload
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1853 - H1860.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H.-Y. Yang, C.-F. Cheng, B. Djoko, W.-S. Lian, C.-F. Tu, M.-T. Tsai, Y.-H. Chen, C.-C. Chen, C.-J. Cheng, and R.-B. Yang
Transgenic overexpression of the secreted, extracellular EGF-CUB domain-containing protein SCUBE3 induces cardiac hypertrophy in mice
Cardiovasc Res, July 1, 2007; 75(1): 139 - 147.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. J. Lee, Q. Fang, P. A. Davol, Y. Gu, R. E. Sievers, R. C. Grabert, J. M. Gall, E. Tsang, M. S. Yee, H. Fok, et al.
Antibody Targeting of Stem Cells to Infarcted Myocardium
Stem Cells, March 1, 2007; 25(3): 712 - 717.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. M. R. Carvalho, R. A. Bassani, K. G. Franchini, and J. W. M. Bassani
Enhanced calcium mobilization in rat ventricular myocytes during the onset of pressure overload-induced hypertrophy
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1803 - H1813.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Kamba, B. Y. Y. Tam, H. Hashizume, A. Haskell, B. Sennino, M. R. Mancuso, S. M. Norberg, S. M. O'Brien, R. B. Davis, L. C. Gowen, et al.
VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature
Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H560 - H576.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. L. Springer, R. E. Sievers, M. N. Viswanathan, M. S. Yee, E. Foster, W. Grossman, and Y. Yeghiazarians
Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1307 - H1314.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Berenji, M. H. Drazner, B. A. Rothermel, and J. A. Hill
Does load-induced ventricular hypertrophy progress to systolic heart failure?
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H8 - H16.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X.-M. Gao, H. Kiriazis, X.-L. Moore, X.-H. Feng, K. Sheppard, A. Dart, and X.-J. Du
Regression of pressure overload-induced left ventricular hypertrophy in mice
Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2702 - H2707.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. W. Holmes
Candidate mechanical stimuli for hypertrophy during volume overload
J Appl Physiol, October 1, 2004; 97(4): 1453 - 1460.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
M. Mirotsou, C. M.H. Watanabe, P. G. Schultz, R. E. Pratt, and V. J. Dzau
Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach
Physiol Genomics, October 17, 2003; 15(2): 115 - 126.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
E. O. Weinberg, M. Mirotsou, J. Gannon, V. J. Dzau, R. T. Lee, and R. E. Pratt
Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload
Physiol Genomics, January 15, 2003; 12(2): 113 - 127.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (32)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, A.
Right arrow Articles by Foster, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, A.
Right arrow Articles by Foster, E.


HOME HELP FEEDBACK